Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 9, 2010, Pages 1582-1587

  Chawla, Varun ^a   Greene, Tom ^b   Beck, Gerald J ^c   Kusek, John W ^d   Collins, Allan J ^e   Sarnak, Mark J ^f   Menon, Vandana ^f  

^a MOUNT AUBURN HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; KIDNEY DISEASES; LIPIDS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES; UNITED STATES;

EID: 77957298855     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01450210     Document Type: Article

References (24)

1. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16-S23, 1998
2. Drey N, Roderick P, Mullee M, Rogerson M: A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42: 677-684, 2003 (Pubitemid 37187367)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003 (Pubitemid 37337595)
5. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
6. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R: Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: 1829-1839, 2007
7. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD: Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284: 311-318, 2000 (Pubitemid 30469857)
8. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322: 1700-1707, 1990 (Pubitemid 20231527)
9. Kasiske BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32: S142-S156, 1998 (Pubitemid 28527270)
10. Coresh J, Longenecker JC, Miller ER III, Young HJ, Klag MJ: Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol 9: S24-S30, 1998
11. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, Levey AS: Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 57: 327-335, 2002 (Pubitemid 34477469)
12. Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61: 1887-1893, 2002
13. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31: 103-110, 1982 (Pubitemid 12045139)
14. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K: Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 18: 293-303, 2007 (Pubitemid 46053442)
15. Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS: The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 21: 2881-2892, 2006 (Pubitemid 44542246)
16. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: Effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol 18: 304-311, 2007
17. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ: Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291: 451-459, 2004 (Pubitemid 38129749)
18. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293: 1737-1745, 2005 (Pubitemid 40491299)
19. Greene T, Bourgoignie JJ, Habwe V, Kusek JW, Snetselaar LG, Soucie JM, Yamamoto ME: Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 4: 1221-1236, 1993
20. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877-884, 1994
21. Kusek JW, Coyne T, de Velasco A, Drabik MJ, Finlay RA, Gassman JJ, Kiefer S, Powers SN, Steinman TI: Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Control Clin Trials 14: 538-557, 1993 (Pubitemid 24003710)
22. Herzog CA, Mangrum JM, Passman R: Sudden cardiac death and dialysis patients. Semin Dial 21: 300-307, 2008
23. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A: Nonlipid-related effects of statins. Ann Med 32: 164-176, 2000
24. Baigent C, Landray M, Warren M: Statin therapy in kidney disease populations: Potential benefits beyond lipid lowering and the need for clinical trials. Curr Opin Nephrol Hypertens 13: 601-605, 2004 (Pubitemid 39506907)